Pulling SEC filings + quote and writing the call…

AtriCure, Inc.
Next earnings Jul 27, 2026 (after close) · consensus $0.01 EPS, $155M rev
Last earnings +2.1% on 2026-05-05
Revenue grew 14.9% YoY; but unprofitable (net margin -2.1%).
AtriCure, Inc. shows $535M in FY2025 revenue (+14.9% YoY), a -2.1% net margin, and -2.3% ROE.
Sources: SEC EDGAR (CIK 0001323885, latest 10-Q filed 2026-05-06) · EODHD · as of 6/26/2026, 1:53:15 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $274M | $330M | $399M | $465M | $535M |
| Gross profit | $206M | $246M | $300M | $348M | $401M |
| Operating income | $55.2M | -$42.7M | -$26.7M | -$40.0M | -$9.45M |
| Net income | $50.2M | -$46.5M | -$30.4M | -$44.7M | -$11.4M |
| Diluted EPS | $1.09 | -$1.02 | -$0.66 | -$0.95 | -$0.24 |
| Net margin | 18.3% | -14.1% | -7.6% | -9.6% | -2.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1 buy · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1071 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Last 90 days: 0 open-market buys · 1 sale
| 2026-05-20 | Prange Karen Director | Sell | 3.00K @ $28.65 | $86.0K |
| 2026-05-18 | Prange Karen Director | Award | 6.14K | |
| 2026-05-18 | Telman Deborah H Director | Award | 6.14K | |
| 2026-05-18 | Yuen Maggie Director | Award | 6.14K | |
| 2026-05-18 | Nachman Shlomo Director | Award | 6.14K | |
| 2026-05-18 | JOHNSON B KRISTINE Director | Award | 6.14K | |
| 2026-05-18 | GROVES REGINA E Director | Award | 6.14K | |
| 2026-05-18 | WEHRWEIN SVEN Director | Award | 6.14K |